You are here: vision-research.eu » News » Newsdetails:

Leading ophthalmologists present real world clinical outcomes on Oraya Therapy for wet AMD

Oraya Therapeutics Inc. has announced that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet age-related macular degeneration (AMD), during a symposium at the European Society of Retina Specialists' 15th Congress in Nice, France.

The results show that Oraya Therapy is effective in maintaining vision with reduced injections for patients at different stages of their disease - from chronic patients in discontinuous treatment to treatment-naive patients with new diagnosis - and following different treatment pathways.

Health Business

Related Links